Second Genome is Drug Discovery in United States that focus on phenotypic screening business. Founded in 2009. They cover business area such as developer, microbial genetic insight, transformational precision therapy, biomarker, genomics technology, computational biology, phenotypic screening, novel protein, peptide, metabolite, researcher, medicine, microbiome science.
2009
( 15 years old in 2024 )
Phenotypic Screening
-
1000 Marina Boulevard
Suite 500
Brisbane, CA 94005
United States
Private
developermicrobial genetic insighttransformational precision therapybiomarkergenomics technologycomputational biologyphenotypic screeningnovel proteinpeptidemetaboliteresearchermedicinemicrobiome science
* We use standard office opening hours in near Second Genome's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Second Genome is Drug Discovery business from United States that founded in 2009 (15 years old in 2024), Second Genome business is focusing on Phenotypic Screening.
Second Genome headquarter office and corporate office address is located in 1000 Marina Boulevard Suite 500 Brisbane, CA 94005 United States.
Second Genome was founded in United States.
In 2024, Second Genome is currently focus on phenotypic screening sector.
Above is snippet of Google Trends for "phenotypic screening" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Second Genome, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
